Part 3 | The EU AI Act and life sciences with Arne Thiermann

  Рет қаралды 48

Hogan Lovells

Hogan Lovells

Күн бұрын

Join us for part three of our series on the EU AI Act and its implications for pharma, med tech, and digital health.
In our first two videos, Hamburg partner Arne Thiermann introduced the basics of the AI Act and its similarities with the Medical Device Regulation, or MDR.
In this third installment, Arne continues to explore this topic, focusing on the key differences and challenges these regulations bring to the med tech sector.
This video is part of our Digital Transformation Academy series. Find and subscribe to more free resources here: digital-client...

Пікірлер
Part 4 | Fake content, fake news, and its legal implications
5:20
Implementing the EU AI Act: Text to Practice  - Holistic AI Policy Hour
1:00:07
Правильный подход к детям
00:18
Beatrise
Рет қаралды 11 МЛН
“Don’t stop the chances.”
00:44
ISSEI / いっせい
Рет қаралды 62 МЛН
Debunking the EU AI Act: an overview of the new legal framework
1:00:21
Fieldfisher Data & Privacy Team
Рет қаралды 17 М.
2025 Economic Outlook with Mohamed El-Erian
55:41
Walker & Dunlop
Рет қаралды 502 М.
Transformers (how LLMs work) explained visually | DL5
27:14
3Blue1Brown
Рет қаралды 4,7 МЛН
Part 2 | The EU AI Act and life sciences with Arne Thiermann
2:48
How to Master AI (Act) Regulation?
1:01:08
Computer & Communications Industry Association
Рет қаралды 1,6 М.
Has Generative AI Already Peaked? - Computerphile
12:48
Computerphile
Рет қаралды 1,1 МЛН
What rights do data subjects have under the AI Act and are they different from the GDPR?
55:15